Atlas Trials

A Single-dose, Randomized, Two-period, Two-treatment, Two-sequence, Crossover Bioequivalence Study on a Olostar Tab Versus Two Co-administered Reference Products Olmesartan Medoxomil and Rosuvastatin Calcium in Healthy Volunteers

Clinical trial NCT02561884 · UNKNOWN

Trial details

NCT number
NCT02561884
Sponsor
Daewoong Pharmaceutical Co. LTD.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2015-10-01
Primary completion
2015-10-01
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.